What is the treatment approach for bronchitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bronchitis

Acute Bronchitis: Antibiotics Are Not Indicated

For uncomplicated acute bronchitis, do not prescribe antibiotics regardless of cough duration or sputum color—this is the single most important recommendation. 1, 2, 3 Viruses cause more than 90% of acute bronchitis cases, and antibiotics provide minimal benefit (reducing cough by only half a day) while causing significant harm including allergic reactions, gastrointestinal symptoms, and promoting antibiotic resistance. 4, 5

Symptomatic Management of Acute Bronchitis

  • Short-acting β-agonists (albuterol) should be offered to patients with evidence of bronchial hyperresponsiveness such as wheezing or prolonged bothersome cough, as they reduce cough duration and severity. 2, 3, 6

  • Ipratropium bromide may improve cough in some patients with acute bronchitis. 2, 3, 6

  • Dextromethorphan or codeine are recommended for short-term symptomatic relief of bothersome cough, though evidence shows they work better for chronic cough (>3 weeks) than early acute cough. 1, 2, 3

  • Expectorants and mucolytics have no proven benefit and should not be used. 2, 3, 6

Patient Communication Strategy

Set realistic expectations by explaining that cough typically lasts 10-14 days after the visit. 1, 3 Refer to the illness as a "chest cold" rather than "bronchitis"—this terminology reduces patient expectation for antibiotics. 1, 3 Emphasize that patient satisfaction depends on quality communication, not antibiotic prescribing. 1, 3


Chronic Bronchitis: Avoidance of Irritants is Cornerstone

Smoking cessation is the most effective intervention for chronic bronchitis, with 90% of patients experiencing cough resolution after quitting. 2, 3, 6 Remove all respiratory irritants including passive smoke and workplace/environmental pollutants. 1

Maintenance Therapy for Stable Chronic Bronchitis

  • Short-acting β-agonists should be used to control bronchospasm, relieve dyspnea, and may reduce chronic cough. 1, 2, 3, 6

  • Ipratropium bromide should be offered to improve cough and reduce sputum volume. 1, 2, 3, 6

  • Long-acting β-agonists combined with inhaled corticosteroids should be offered to control chronic cough. 1, 2, 3, 6

  • Inhaled corticosteroids alone should be offered to patients with FEV1 <50% predicted or those with frequent exacerbations (≥4 per year). 1, 6

  • Theophylline may be considered to control chronic cough but requires careful monitoring for complications. 1

What NOT to Use in Stable Chronic Bronchitis

  • Long-term prophylactic antibiotics are not recommended. 1, 6
  • Oral corticosteroids have no proven benefit and high risk of side effects. 3
  • Expectorants, postural drainage, and chest physiotherapy have no proven benefit. 1, 6

Acute Exacerbations of Chronic Bronchitis: The Anthonisen Criteria Matter

When to Treat with Antibiotics

Antibiotics are recommended for acute exacerbations when at least 2 of the 3 Anthonisen criteria are present: increased dyspnea, increased sputum volume, and increased sputum purulence. 1 Antibiotics are particularly important for patients with severe exacerbations and baseline FEV1 <50%. 2, 6, 7

The French guidelines provide a more nuanced approach based on disease severity:

  • Simple chronic bronchitis (FEV1 >80%, no dyspnea): Antibiotics NOT recommended initially; only if fever >38°C persists beyond 3 days. 1

  • Obstructive chronic bronchitis (FEV1 35-80%, exertional dyspnea): Antibiotics recommended immediately if ≥2 Anthonisen criteria present. 1

  • Severe obstructive chronic bronchitis with respiratory insufficiency (FEV1 <35%, dyspnea at rest, hypoxemia): Antibiotics recommended immediately. 1

Antibiotic Selection

First-line antibiotics (for infrequent exacerbations <3/year, FEV1 ≥35%): Amoxicillin remains the reference; alternatives include first-generation cephalosporins, macrolides, or doxycycline. 1

Second-line antibiotics (for frequent exacerbations ≥4/year or FEV1 <35%): Use amoxicillin/clavulanate, respiratory fluoroquinolones, or extended-spectrum agents. 1, 8

Azithromycin 500mg daily for 3 days showed 85% clinical cure rate at day 21-24 for acute exacerbations, comparable to 10 days of clarithromycin. 7

Bronchodilators and Corticosteroids for Exacerbations

  • Short-acting β-agonists or anticholinergic bronchodilators should be administered immediately; if no prompt response, add the other agent. 1, 2, 3, 6

  • Systemic corticosteroids (10-15 day course) are effective for acute exacerbations and should be given. 2, 6

  • Theophylline should NOT be used for acute exacerbations. 1, 6


Critical Pitfalls to Avoid

  • Do not prescribe antibiotics based solely on colored/purulent sputum—this reflects inflammatory cells, not bacterial infection. 2, 3

  • Rule out pneumonia before diagnosing bronchitis by assessing for tachycardia, tachypnea, fever >100.4°F, and focal lung findings; obtain chest X-ray if any are present. 2, 3, 5

  • Consider pertussis if cough persists >2 weeks with paroxysmal features, whooping, or post-tussive emesis. 5

  • Recognize congestive heart failure as a mimic of chronic bronchitis exacerbation, especially in patients with known cardiac disease. 9

  • Do not overlook high-risk populations where antibiotics may be considered for acute bronchitis: age ≥75 years with fever, or patients with cardiac failure. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Bronchitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Bronchitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and treatment of acute bronchitis.

American family physician, 2010

Research

Acute Bronchitis.

American family physician, 2016

Guideline

Bronchitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Challenging questions in treating bronchitis.

Missouri medicine, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.